Correlation Between Kiniksa Pharmaceuticals and Cogent Biosciences

Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Cogent Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Cogent Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Cogent Biosciences, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Cogent Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Cogent Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Cogent Biosciences.

Diversification Opportunities for Kiniksa Pharmaceuticals and Cogent Biosciences

0.88

Correlation Coefficient

Kiniksa Pharmaceuticals  Cogent Biosciences

Very poor diversification

The 3 months correlation between Kiniksa and Cogent is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Cogent Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cogent Biosciences and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Cogent Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cogent Biosciences has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Cogent Biosciences go up and down completely randomly.

Pair Corralation between Kiniksa Pharmaceuticals and Cogent Biosciences

Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 0.94 times more return on investment than Cogent Biosciences. However, Kiniksa Pharmaceuticals is 1.06 times less risky than Cogent Biosciences. It trades about 0.03 of its potential returns per unit of risk. Cogent Biosciences is currently generating about 0.0 per unit of risk. If you would invest  1,859  in Kiniksa Pharmaceuticals on September 25, 2024 and sell it today you would earn a total of  134.00  from holding Kiniksa Pharmaceuticals or generate 7.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Kiniksa Pharmaceuticals  vs.  Cogent Biosciences

Kiniksa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kiniksa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cogent Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cogent Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Kiniksa Pharmaceuticals and Cogent Biosciences

The main advantage of trading using opposite Kiniksa Pharmaceuticals and Cogent Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Cogent Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cogent Biosciences will offset losses from the drop in Cogent Biosciences' long position.

The idea behind Kiniksa Pharmaceuticals and Cogent Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.